Dental implants and bone medicines: prescriptions that must be disclosed

Before implant treatment, tell the dentist about every medicine used for bone disease, including infrequent injections and courses that ended some time ago. The exact medicine, reason for prescribing it and treatment schedule matter. “I take calcium” is not a medication history: products that people describe as “bone treatment” may have quite different implications for surgery.

Identify the medicine and why it was prescribed

Bisphosphonates and denosumab are among the medicines associated with discussion of medication-related osteonecrosis of the jaw. This is a serious complication, but its likelihood depends on the indication and regimen. Treatment for osteoporosis should not automatically be equated with more intensive cancer-related schedules. The ADA explicitly distinguishes these settings.

Use prescriptions or packaging to prepare the generic and brand names, how the medicine is given, when treatment started and the date of the last dose. If details are missing, request a summary from the prescribing clinician. Do not identify the medicine solely from a tablet’s colour or how often you attend an injection appointment.

Include other prescriptions and health conditions, even if they seem unrelated to dentistry. Specifically mention earlier healing difficulties, unusual jaw sensations and treatment for cancer. That context allows the dentist to decide which medical input is needed before an intervention.

Separate implant planning from necessary dental care

Taking an antiresorptive medicine for osteoporosis does not by itself automatically rule out dental implants. The ADA notes that larger, longer-term studies are needed to assess outcomes more reliably. The decision remains individual; this conclusion should not be extended to cancer treatment regimens.

An elective implant and treatment of an existing dental disease are different decisions. Avoiding all dental care out of fear can create problems of its own. SDCEP advises discussion with the doctor and dentist, including treatment alternatives.

Divide the consultation into two questions: what does your mouth need now, and which replacement option is appropriate once the individual risks have been considered? If an implant is not currently advised, the explanation should cover other ways to restore function and what might lead to reassessment. Excluding one intervention should still leave you with an understandable care plan.

Do not arrange your own medication break

Do not stop or reschedule a prescribed medicine for a dental visit yourself. A break is not a universal way of protecting the jaw, and the medical benefit of treatment remains part of the decision. For osteoporosis treatment, the ADA finds insufficient evidence for recommending a routine medication holiday to everyone before dental care.

If a clinic proposes stopping treatment, obtain an agreed written position from the prescribing clinician. It should identify the particular intervention and the individual reasons for any change. Similarly, one laboratory test cannot be treated as a certificate of zero risk. A promise that complications can be completely excluded deserves careful questioning.

Leave the consultation with a shared plan

A useful outcome is a recorded assessment, a proposed dental approach and responsibility for follow-up. For travel, clarify which decisions can be made from records and what needs an examination. Avoid paying for an irreversible stage while the clinicians still have an unresolved question about medication arrangements.

Contact a dentist promptly if you notice exposed bone, discharge, swelling, pain or a new unusual sensation in the jaw. These findings do not prove osteonecrosis, but they need assessment; sending photographs abroad should not delay it.

The medical travel medicines checklist can help with the practical record of prescriptions. When requesting treatment assessment in Turkey, clearly state that you need the dental plan reviewed in light of both current and previous treatment for bone disease.

Sources

Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.